Course Schedule

Course # Course Name Fall
A | B
Spring
A | B
Summer
A | B
Prerequisites & Notes
PHA 5270 Health Care & Patient Safety   B    
PHA 5271 Health Care Risk Management B      
PHA 6269 Pharmaceutical Products & Public Policy   B    
PHA 6273/6935* Structure, Process & Outcomes of Regulation     A  
PHA 6274 Federal Regulation of Drugs & Pharmacy B     It is strongly recommended that students take PHA (6273/6935) Structure, Process & Outcomes of Regulation prior to taking this course.
PHA 6275 Federal Regulation of Controlled Substances     B  
PHA 6276 Pharmacy Benefit Design & Management     B  
PHA 6277 Ethics in Drug Production, Distribution & Use   A    
PHA 6278 State Regulation of Drugs & Pharmacy     A 1. Offered every other year, in even-numbered years (e.g., 2020, 2022).  
2. It is recommended that students take PHA (6273/6935) Structure, Process & Outcomes of Regulation prior to taking this course.
PHA 6279 Pharmaceutical Outcomes & Policy Seminar   A/B Break   Course includes both Web-based and in-person assignments.  In-person attendance is required for two-day (Sat-Sun) event, held on campus in Gainesville, FL.  
PHA 6280 Medicare & Medicaid   A    
PHA 6283 Commercial Applications / Pharmacoecon. Principles B B    
PHA 6286 Pharmaceutical Microeconomics A      
PHA 6287 Pharmaceutical Health Economics   B    
PHA 6793 Evidentiary Basis of Pharmaceutical Use B      
PHA 6799 Medication Safety and Quality Program Evaluation     A Note that this course was previously offered in Summer B terms, but is now permanently scheduled for Summer A.
PHA 6806 Pharmacoeconomic Modeling     A/B* Prereqs:  1)Satisfactory completion of PHA 6283 Commercial Applications of Pharmacoeconomic Principles, and, 2) Satisfactory completion of PHA 6935 Quantitative Methods for Evidence-Based Pharmacy OR firm understanding of basic statistics.  

*Offered twice, in both Summer A and Summer B.  Enrollment in the course may be capped.  Students are advised to register for their selected term (A or B) as early as possible.
PHA 6891 Introduction to Pharmacoepidemiology A      
PHA 6935* Managed Prescription Drug Systems B     Prereq: Satisfactory completion of PHA 6276 Pharmacy Benefit Design & Management OR permission of the instructor.
PHA 6211 Managed Care Pharmacy Operations A     Prereq: Satisfactory completion of PHA 6276 Pharmacy Benefit Design & Management OR permission of the instructor.
PHA 6246 Medication Safety and Technology B      
PHA 6935* Pharm Data Analysis I: Data Management   B   Prereqs:  
1)Satisfactory completion of PHA 6283 Commercial Applications of Pharmacoeconomic Principles, and, 
2) Satisfactory completion of PHA 6935 Quantitative Methods for Evidence-Based Pharmacy OR firm understanding of basic statistics.  
PHA 6935* Pharm Data Analysis II: Risk Adjustment     A Students must complete PHA 6935 Pharm. Data Analysis I: Data Management prior to taking this course.
PHA 6186 POP Foundations I: Drug Discovery to Approval A     The POP Foundation series includes two courses, POP Foundations I and POP Foundations II.  Each course is independent, and students are not required to take POP Foundations I prior to taking POP Foundations II.  
PHA 6187 POP Foundations II: Marketing & Use   A   The POP Foundation series includes two courses, POP Foundations I and POP Foundations II.  Each course is independent, and students are not required to take POP Foundations I prior to taking POP Foundations II.  
PHA 6935* Medication
Error Prevention
    B Note that this course was previously offered in Summer A terms, but is now permanently scheduled for Summer B.
PHA 6795 Quantitative Methods in Evidence-Based Pharmacy     A  
PHA 6935* Writing for Pharmacy Outcomes & Policy (POP) A B Summer C 1. M.S. Students must successfully complete this course prior to taking their comprehensive final exam.  
2. The Fall and Spring versions of this course are offered over a half-semester (7-8 weeks) and may require students to complete writing assignments on a short turnaround during the work week.  The Summer version of this course is stretched over the entire Summer C semester (Summer A + B, or 12-13 weeks).  Students in the Summer course generally have more lead-time to complete assignments, and may not need to work on assignments during the work week.    
PHA 6791 Systematic Review & Meta-Analysis for Pharmaceutical Interventions   B   Prior to taking this course, students must complete PHA 6793 Evidentiary Basis of Pharmaceutical Use (or its equivalent), and must have had prior graduate-level statistics coursework or undergraduate-level applied statistics. Students without prior statistics courses may be required to take PHA 6935 Quantitative Methods in Evidence-Based Pharmacy.
PHA 6797  Applied Pharmaceutical Research Communications   A    
MMC 5435  Messaging Strategy and the Value Proposition UF Fall semester: A/B     This is a full semester course, based on the standard UF academic calendar for the Fall semester. Course start and end dates may differ from other program courses.
MMC 6456 Data Storytelling and Visualization UF Fall semester: A/B     This is a full semester course, based on the standard UF academic calendar for the Fall semester. Course start and end dates may differ from other program courses.

*PHA 6935 is used for courses that have not yet been assigned a permanent number in the Statewide Course Numbering System.  

NOTE: Course offerings are subject to enrollment minimums and may be changed at any time.